CRS, thought to be due to T‐cell activation, is characterised by marked elevation of inflammatory markers and cytokines notably IL‐6, fever, hypotension and respiratory insufficiency following the infusion of CAR T cells or other immune therapies.33, 34. This evidence concerns the gene IL6 and congenital rubella syndrome.